- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 15.75M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 15.75M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 14.8M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$543K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$271K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.11M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.72M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $8.74M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $9.22M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $9.77M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $10.49M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.68M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.66M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.4M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.52M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $6.08M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $6.3M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $11.14M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $11.74M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.06 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.48M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.36M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $303K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $434K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$338K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$805K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$450K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$849K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $1.34M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $949K |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.07M |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.66M |
| Capex | Q1 2026 · Mar 31, 2025 | $29K |